CHINARES PHARMA Affirms 6.28 Billion Outstanding Shares and Adequate Public Float in July 2026 Return

Bulletin Express08-03

China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its monthly return for the period ended 31 July 2026, confirming that the total number of issued ordinary shares remained unchanged at 6.28 billion. No treasury shares were held or cancelled during the month.

The company verified compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity.

Under the approved share-option scheme (12 December 2017), CHINARES PHARMA reported no outstanding options at month-end. However, up to 628.45 million additional shares may still be issued under the existing mandate, offering future flexibility for equity-based incentives.

The filing noted no warrants, convertibles, or other share-issuance arrangements, and no movements in authorised or registered share capital.

The monthly return was submitted on 3 August 2026 by Company Secretary Wan Wing Yi Carol.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112109803?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112109803","market":"us","top_or_hot":-1,"title":"CHINARES PHARMA Affirms 6.28 Billion Outstanding Shares and Adequate Public Float in July 2026 Return","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its monthly return for the period ended 31 July 2026, confirming that the total number of issued ordinary shares remained unchanged at 6.28 billion. No treasury shares were held or cancelled during the month.</p>\n<p>The company verified compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity.</p>\n<p>Under the approved share-option scheme (12 December 2017), CHINARES PHARMA reported no outstanding options at month-end. However, up to 628.45 million additional shares may still be issued under the existing mandate, offering future flexibility for equity-based incentives.</p>\n<p>The filing noted no warrants, convertibles, or other share-issuance arrangements, and no movements in authorised or registered share capital.</p>\n<p>The monthly return was submitted on 3 August 2026 by Company Secretary Wan Wing Yi Carol.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHINARES PHARMA Affirms 6.28 Billion Outstanding Shares and Adequate Public Float in July 2026 Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHINARES PHARMA Affirms 6.28 Billion Outstanding Shares and Adequate Public Float in July 2026 Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-03 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its monthly return for the period ended 31 July 2026, confirming that the total number of issued ordinary shares remained unchanged at 6.28 billion. No treasury shares were held or cancelled during the month.</p>\n<p>The company verified compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity.</p>\n<p>Under the approved share-option scheme (12 December 2017), CHINARES PHARMA reported no outstanding options at month-end. However, up to 628.45 million additional shares may still be issued under the existing mandate, offering future flexibility for equity-based incentives.</p>\n<p>The filing noted no warrants, convertibles, or other share-issuance arrangements, and no movements in authorised or registered share capital.</p>\n<p>The monthly return was submitted on 3 August 2026 by Company Secretary Wan Wing Yi Carol.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1112109803","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112109803","pubTimestamp":1785750469,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its monthly return for the period ended 31 July 2026, confirming that the total number of issued ordinary shares remained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"CHINARES PHARMA 确认 2026 年 7 月 62.8 亿股流通股和足够的公众持股量回报","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its monthly return for the period ended 31 July 2026, confirming that the total number of issued ordinary shares remained unchanged at 6.28 billion. No treasury shares were held or cancelled during the month.\nThe company verified compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%, indicating sufficient free-float liquidity.\nUnder the approved share-option scheme (12 December 2017), CHINARES PHARMA reported no outstanding options at month-end. However, up to 628.45 million additional shares may still be issued under the existing mandate, offering future flexibility for equity-based incentives.\nThe filing noted no warrants, convertibles, or other share-issuance arrangements, and no movements in authorised or registered share capital.\nThe monthly return was submitted on 3 August 2026 by Company Secretary Wan Wing Yi Carol.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112109803","isCrawlerRequest":true}